An Open-Label Study to Investigate the Safety of Single Ascending Doses in Children and Adolescents With Dravet Syndrome
Summary
- Eligibility
- for people ages 2-18 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Stoke Therapeutics, Inc
- ID
- NCT04442295
- Phase
- Phase 1/2
- Study Type
- Interventional
- Last Updated